Supplemental Figure 3:
Real-time analyses of BRD4 mRNA expression in the indicated lines (P: Parental, eR: eveR, L: LTED, LeR: LTED-eveR). Data is represented as fold change over parental controls with standard deviation in the histogram.
Supplemental Figure 4
A. Proliferation of indicated cells lines was measured after five days of the indicated treatments. Evero: 500nM everolimus, JQ1: 500nM. Average net growth is shown with standard deviation in the histograms. B. ZR75 derivatives were plated in 96-well plates in triplicate in the absence of drug. One day after plating, everolimus and JQ1 were added at the indicated concentrations. Cells were incubated for five days before proliferation was measured by CellTiterGlo. Average percent net growth is depicted in the tables with a value of "0" representing 100% growth inhibition, a value of "100" representing 0% growth inhibition and a value of "-100" representing 100% cell death. 
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